Find Academic Supervisors

• Epidemiology of infectious diseases
• HIV/AIDS
• Sexually transmitted infection
• +8 more

Marie-Claude Boily serves as Professor of Mathematical Epidemiology at Imperial College London's School of Public Health within the Faculty of Medicine. Her research employs mathematical modeling, statistical analysis, and empirical studies to investigate infectious disease epidemiology with primary focus on HIV/AIDS and sexually transmitted infections across developing and developed countries. Her core research areas include: Transmission dynamics of HIV in evolving epidemics (particularly in Africa and India) Impact assessment of interventions including HPV vaccination and prevention of mother-to-child transmission Rigorous measure and evaluation frameworks using transmission dynamic models Sexual network structures and behavioral determinants in HIV spread Analysis of her publication record (2000-2009) reveals consistent application of mathematical models to evaluate HIV prevention strategies, with strong emphasis on simulating community trials before implementation. Her work bridges epidemiological theory with public health practice, developing tools for cost-effective intervention assessment in resource-limited settings. Professor Boily actively supervises PhD students Sharmistha Mishra, Branwen Owen, Juan Vesga, Isabel Tavitian-Exley, and Nicolas Van de Velde, while collaborating with research associates across Imperial College London, IARC, U Laval, LSE, and UBC. Her team integrates serial biological and behavioral data with sophisticated modeling to inform HIV prevention policies and trial designs globally.

Arne MillerView profile

Researcher

• Radiation Dosimetry
• Nuclear Physics
• Environmental Radiation Monitoring
• +3 more

Arne Miller is a Specialist Consultant at the Department of Health Technology Dosimetry, Technical University of Denmark. His research focuses on radiation dosimetry, nuclear physics, and polymer science for radiation processing. Key research areas include X-ray beam quality analysis, development of radiochromic and radiofluorogenic polymer materials for dose profiling, and comparative studies of microbicidal effectiveness in sterilization techniques. Recent work emphasizes thermal stability of dosimeters and calibration standards for gamma radiation. He supervises PhD students such as L. L. Nissen, M. M. Skowyra, and J. G. Hjørringgaard, contributing to projects on radiation processing dosimetry and medical device sterilization.

Salim S. Abdool KarimView profile

Professor

• HIV Prevention
• HIV Treatment
• TB-HIV Co-infection
• +5 more

Salim S. Abdool Karim serves as CAPRISA Professor of Global Health in the Department of Epidemiology at Columbia University's Mailman School of Public Health. He concurrently holds leadership roles as Director of the Centre for the AIDS Program of Research in South Africa (CAPRISA), Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal, and Adjunct Professor of Medicine at Weill Cornell Medical College. His academic credentials include an MBBCH from the University of Natal (1983), an MS from Columbia University (1988), and a PhD from the University of Natal (1999). A clinical infectious diseases epidemiologist, Dr. Abdool Karim pioneered HIV prevention research through the landmark CAPRISA 004 tenofovir gel trial, demonstrating that antiretrovirals can prevent HIV and HSV-2 transmission in women. His work on TB-HIV co-infection has directly shaped WHO treatment guidelines, while his research spans microbicides, vaccines, epidemiology, and the social determinants of HIV transmission. His publication record reveals sustained focus on HIV prevention mechanisms, pharmacokinetics of antiretrovirals, and implementation science, with recent work emphasizing women-centered prevention strategies and broadly neutralizing antibodies. This trajectory demonstrates consistent leadership in translating basic science into public health interventions. His scientific recognition includes the 2024 Lasker Award and Michael Faraday Prize, alongside election to the US National Academy of Medicine (2013) and multiple global academies. He chairs UNAIDS and WHO advisory panels while serving on editorial boards of the New England Journal of Medicine and Lancet journals. As CAPRISA Director, he oversees a multinational research consortium addressing HIV pathogenesis, tuberculosis linkages, and capacity building through fellowships across South Africa and the United States, maintaining active grant funding for translational research in resource-limited settings.

Anke HemmerlingView profile

Professor

• Global Women's Health
• Sexually Transmitted Infections
• HIV/AIDS Prevention
• +12 more

Anke Hemmerling is a faculty member at the School of Public Health at the University of California, Berkeley, where she serves as Director of the Interdisciplinary MPH Program. She is also a project director at the UCSF Bixby Center for Global Reproductive Health and holds affiliations with the UCSF Global Health Sciences Masters Program. Her work bridges clinical medicine and public health with a focus on global women’s health and infectious diseases. Research Interests: Dr. Hemmerling's research integrates clinical and public health approaches to address critical issues in sexual and reproductive health. Her work focuses on HIV/AIDS and STI prevention, safe motherhood, family planning, infertility, and the development of multipurpose prevention technologies. She has conducted significant research on medication abortion using mifepristone, misoprostol for postpartum hemorrhage in low-resource settings, and the use of live biotherapeutic products like lactobacilli to prevent genital infections. Scientific Awards and Recognition: UCB Bixby Fellow of Population, Family Planning and International Health Advising and Grants: Dr. Hemmerling mentors medical students, graduate students, post-doctoral fellows, and undergraduate public health majors through programs such as the UCSF Infectious Disease Research and Training Program (IDRTP), the UCSF Global Health Masters Program, and the UCB Interdisciplinary MPH Program. She leads research projects funded by major institutions, including NIH-sponsored clinical trials, and serves on safety and monitoring boards for these studies. Labs and Teams: She is a key member of the UCSF Bixby Center for Global Reproductive Health, where she leads studies on live biotherapeutic products for HIV and genital infection prevention in the U.S. and South Africa. She also contributes to the UC Global Health Institute Center of Expertise in Women’s Health and Empowerment as a member of its Education Committee. Additionally, she serves as a senior scientific advisor and steering committee member for the Coalition Advancing Multipurpose Innovations (CAMI) and on the Population Council Microbicide Advisory Board.

• HIV/AIDS Research
• Cell Biology
• Virology
• +6 more

Thomas J. Hope is a Professor of Cell and Molecular Biology (Feinberg School of Medicine) and Biomedical Engineering (McCormick School of Engineering) at Northwestern University. His research focuses on HIV cellular virology, mucosal immunology, and prevention science, using advanced imaging techniques to study viral entry, assembly, and transmission dynamics. He leads the Hope Lab, which pioneers microscopic imaging of HIV interactions with cells and tissues to inform HIV prevention strategies like vaccines and microbicides. His work integrates molecular biology, biochemistry, and genetics to address early HIV transmission steps and develops tools for in vivo tracking of viral particles. Education: PhD in Immunology from UC Berkeley (1988), postdoctoral fellowship at UCSF (1992). His lab’s recent work includes SARS-CoV-2 studies, exploring mucociliary clearance effects on viral spread and PET/CT imaging of HIV distribution. Collaborations span HIV cure research, including TGF-β blockade to reactivate latent reservoirs, and global PrEP strategy evaluations. Publications highlight interdisciplinary approaches, with a focus on viral dynamics, antibody distribution, and innovative imaging. The lab’s translational efforts aim to reduce HIV transmission through better understanding of mucosal barriers and immune responses.

Ronald VeazeyView profile

Professor

• HIV/SIV Pathogenesis
• Mucosal Immunology
• Vaccine Development
• +3 more

Dr. Ronald Veazey is a Tenured Professor of Pathology and Chair of the Division of Comparative Pathology at the Tulane National Primate Research Center (TNPRC). He specializes in HIV/SIV pathogenesis, mucosal immunology, and vaccine development using non-human primate models. His research focuses on early viral transmission, immune responses, and reservoir persistence, with over 200 peer-reviewed publications. Education: DVM from Oklahoma State University (1987), PhD in Veterinary Pathology from Louisiana State University (1992), and postdoctoral training at Harvard University (1992–1994). Research interests include mucosal immunity, neonatal immunology, and the role of alcohol in accelerating HIV/AIDS progression. He leads studies on HIV prevention strategies, such as microbicides and vaccines, and collaborates with NIH committees like the Simian Vaccine Evaluation Units (SVEU). Key contributions include identifying the gastrointestinal tract as a major HIV/SIV reservoir and demonstrating alcohol’s role in exacerbating viral replication. He serves on editorial boards for journals such as AIDS Research and Human Retroviruses and Pathogens and Immunity . Labs/Teams: Directs a lab at the TNPRC focused on HIV/AIDS pathogenesis and prevention, collaborating with institutions like the Bill and Melinda Gates Foundation and the NIH AIDS Vaccine Study Section.

Susan Cu-UvinView profile

Professor

• HIV/AIDS Research
• Women's Health
• Microbicides
• +5 more

Susan Cu-Uvin is a Professor of Health Services, Policy and Practice at Brown University’s School of Public Health, and a Professor of Medicine and Obstetrics & Gynecology at the Alpert School of Medicine. She serves as Director of the Brown Global Health Initiative and Principal Investigator of a D43 HIV and Cervical Cancer Training Grant with Moi University in Kenya. Her leadership roles include directing the Providence/Boston Center for AIDS Research (CFAR) and previously leading the Immunology Center at The Miriam Hospital. Her research focuses on HIV in women, particularly antiretroviral therapy’s impact on genital tract viral dynamics, HPV-related cervical/anal dysplasia in HIV-positive women, and microbicide development. She leads studies on HIV transmission prevention, including mucosal immunity and pre-exposure prophylaxis (PrEP). Her work integrates clinical, translational, and global health perspectives, with a focus on reducing health disparities in resource-limited settings. Education & Training: Extensive global health training programs, including the Fogarty International Center’s AIDS International Research and Training Program. Grants: PI/Co-I on NIH-funded projects studying HIV reservoirs in genital tracts, cervical cancer prevention in Kenya, and hormonal influences on HIV susceptibility. Awards: Recipient of the Constance B. Wofsy Women’s Health Investigator Award for her work in the AIDS Clinical Trials Group. Her research has advanced understanding of HIV transmission mechanisms, genital tract immunology, and the intersection of HIV with co-infections like HPV. She collaborates internationally, particularly in Sub-Saharan Africa and Southeast Asia, to address cervical cancer screening and treatment gaps among HIV-positive populations.

Kate M GuthrieView profile

Professor

• acceptability
• adherence
• behavioral medicine
• +15 more

Dr. Kate M. Guthrie is a Professor of Psychiatry and Human Behavior and Professor of Behavioral and Social Sciences at Brown University, holding dual appointments in the Alpert Medical School and the School of Public Health. She serves as the Director of the Qualitative Science & Methods Training Program and a Senior Research Scientist at The Miriam Hospital's Center for Behavioral & Preventive Medicine. Her research focuses on perceptibility (user sensory experiences) in biomedical/pharmaceutical development, particularly for HIV prevention and palliative care. She has pioneered frameworks linking sensory experiences to product acceptability and adherence. Education: PhD in Clinical Psychology, Western Michigan University (1996) Postdoctoral Fellowship at Brown University's Centers for Alcohol & Addiction Studies (1996-1998) Research Interests: Dr. Guthrie's work spans behavioral medicine, HIV/STI prevention, and chronic illness care. She develops mixed-methods approaches to evaluate user experiences with biomedical products, focusing on sensory perceptions that influence adherence. Her recent projects include optimizing non-hormonal contraceptive vaginal rings, palliative care for pulmonary hypertension patients, and yoga interventions for diabetes management. She also investigates patient-clinician communication and end-of-life care processes. Scientific Awards: 2022 OWIMS Leadership Award 2011 Betty Marcus Women's Health Award 2010-2011 Brown University Faculty Mentoring Award 2003 Society of Behavioral Medicine Annual Meeting Citation Grants & Collaborations: Dr. Guthrie leads NIH-funded projects, including R01 grants for yoga in diabetes and vaginal ring development. She collaborates with researchers like Dr. Rochelle Rosen (qualitative methods) and Dr. Megan Ranney (emergency medicine). Her work also interfaces with engineering teams to design user-centric pharmaceutical formulations. Labs & Teams: She directs the Qualitative Science & Methods Training Program, mentoring over 50 trainees. Her lab actively partners with bioengineers and clinicians to advance patient-centered healthcare technologies.

Lisa Cencia RohanView profile

Professor

• Drug Delivery
• Pharmaceutics
• Pharmaceutical Product Development
• +5 more

Lisa Cencia Rohan is a Professor in the Department of Pharmaceutical Sciences at the University of Pittsburgh’s School of Pharmacy, with cross-appointments in the Department of Obstetrics, Gynecology, and Reproductive Sciences (School of Medicine) and the Clinical and Translational Science Institute. She is also an Investigator at the Magee-Womens Research Institute. Dr. Rohan holds a BS in Chemical Engineering and a PhD in Pharmaceutical Sciences, followed by a Postdoctoral Fellowship in Mucosal Immunology. Her research focuses on drug delivery systems for HIV prevention, particularly vaginal and rectal microbicides, with a strong emphasis on translating preclinical findings into clinical applications. She has developed over 50 pharmaceutical products, 13 of which have advanced to clinical implementation. Current projects include optimizing microbicide formulations (films, gels, tablets) and evaluating their safety, pharmacokinetics, and pharmacodynamics in human tissues. Her work spans interdisciplinary collaborations, addressing global health challenges through innovations in antiretroviral delivery. Notable contributions include studies on dapivirine and tenofovir-based microbicides, nanoparticle drug carriers, and the impact of endogenous and exogenous factors (e.g., hormones, lubricants) on microbicide efficacy. Dr. Rohan has led Phase I/II clinical trials and contributed to large-scale studies on HIV prevention in sub-Saharan Africa. She emphasizes user-centered design and community engagement in product development to ensure practical applicability. Grants and funding have supported her lab’s exploration of novel antiviral compounds (e.g., RC-101, EFdA) and combination therapies. Her team investigates drug transporters and metabolic enzymes in genital tissues to optimize drug bioavailability. Despite no explicitly listed awards, her extensive publication record and clinical trial leadership reflect significant recognition in the field.

• Clinical Sciences
• Medical Microbiology
• Pharmacology and Pharmaceutical Sciences
• +3 more

Dr. Carolina Herrera is an Honorary Senior Research Fellow in the Department of Infectious Disease at Imperial College London's Faculty of Medicine . She holds affiliations with the Immuno-Pathology Network, Microbiome Network, and the Section of Immunology of Infection. Her research focuses on mucosal infection and inflammation, particularly using ex vivo tissue models to study HIV/SIV, HCV, and Zika virus transmission, as well as evaluating prevention strategies like pre-exposure prophylaxis (PrEP) and vaccines. Education : BSc in Chemistry and PhD in Biochemistry from the University of Barcelona, Spain. Postdoctoral training at Weill Medical College of Cornell University, USA, under Prof. John P. Moore. Research Interests : Mucosal immunity and viral transmission Preclinical evaluation of antiviral candidates Inflammation and microbial interactions in infectious diseases Her work has been funded by organizations including NIH, amfAR, EU Commission, and industry partners like Pfizer and Gilead. She has contributed to advancements in understanding HIV pathogenesis and developing innovative prevention tools through interdisciplinary collaborations.

• Immunology
• Clinical Sciences
• Paediatrics and Reproductive Medicine
• +3 more

Dr. Julia Makinde is an Honorary Lecturer in the Department of Infectious Disease at Imperial College London's Faculty of Medicine. She is based at the IAVI Human Immunology Laboratory and works on the ADVANCE programme, funded by the International AIDS Vaccine Initiative. Her research focuses on understanding natural and vaccine-induced immune responses to HIV, aiming to develop new interventions. She is also a Senior Manager in Clinical Immunology, leading projects on immune mediators in the female genital tract and cyclical immunological changes relevant to HIV prevention strategies. Her academic affiliations include the Vaccine Research Network and Chelsea and Westminster Hospital. Key research themes include CD8 T-cell mediated viral inhibition, IL-21 receptor expression in HIV disease, and mucosal immunity dynamics across the menstrual cycle. She has contributed to systematic reviews and meta-analyses of cervicovaginal immunology and developed protocols for T-cell line enrichment and assay controls in HIV research. Dr. Makinde's work spans clinical and translational research, with a focus on bridging immunological discoveries to practical applications in vaccine development and public health. Her recent studies emphasize cross-clade T-cell responses and biomarkers predicting HIV control, alongside investigations of drug transporter modulation for microbicide optimization.

• Mucosal Infection Mechanisms
• Vaccine Development
• HIV Microbicide Research
• +6 more

Professor Robin Shattock is the Head of Mucosal Infection and Immunity within the Department of Medicine at Imperial College London. He leads a team of 26 staff including researchers, PhD students, and project managers. His research focuses on mucosal infection mechanisms and novel vaccine strategies for global health challenges, particularly HIV. He has published over 160 peer-reviewed articles and secured funding from major organizations including the Bill and Melinda Gates Foundation, Wellcome Trust, and EU Framework Programmes. Affiliations: Centre for Advanced Therapeutics, Future Vaccine Manufacturing Research Hub, Immuno-Pathology Network, Vaccine Research Network. Key Projects: Leads ADITEC (Advanced Immunisation Technologies), BioVacSafe (vaccine safety biomarkers), and EAVI2020 (HIV vaccine development consortium). Coordinates the DNAVAC project under the Collaboration for AIDS Vaccine Discovery (CAVD). Research interests span DNA vaccination technologies, immune monitoring, and translational vaccine development. His work emphasizes preclinical-to-clinical pipelines for HIV and other infectious diseases. Grants and collaborations include EU H2020, IMI, and NIH support. Oversee experimental medicine trials for promising HIV vaccine candidates. Labs/Teams: Directs the Shattock Lab focused on mucosal immunity and vaccine design, collaborating with global networks across 23 institutions.

• Bioinformatics
• Computational Biology
• Microbiology
• +3 more

Pawel Gajer is a Research Associate at the Institute for Genome Sciences and faculty member in the Department of Microbiology and Immunology at the University of Maryland School of Medicine. His work focuses on bioinformatics and microbiome research, particularly in vaginal bacterial communities and their impact on reproductive health. PhD in Mathematics (SUNY Stony Brook, 1993) Postdoctoral training in Computational Biology (Johns Hopkins University, 2000-2002) His research develops statistical methods for analyzing genomic data, including community state types, temporal dynamics of vaginal microbiota, and connections between microbial structures and preterm delivery. He has pioneered spline and Taylor expansion mixed-effect models to study microbiome stability. Recent publications highlight investigations into vaginal microbiota across pregnancy outcomes, bacterial vaginosis episodes, and infectious agents like Chlamydia caviae. His work intersects microbiology, computational biology, and clinical research. Collaborations with researchers such as Jacques Ravel and Larry Forney have led to key publications in journals like Science Translational Medicine and Microbiome. He contributes to methodological advancements in microbiome sequencing and data analysis.

Craig CohenView profile

Professor

• Pelvic Inflammatory Disease
• Bacterial Vaginosis
• Sexually Transmitted Infections Prevention
• +7 more

Craig Cohen is a Professor in Residence at the University of California, San Francisco (UCSF) and serves as Co-Director of the UC Global Health Institute. He is affiliated with Zuckerberg San Francisco General Hospital and works within the Department of Obstetrics, Gynecology and Reproductive Sciences. His educational background includes: B.A. in Molecular Biology from UC Berkeley (1984) M.D. from University of Louisville School of Medicine (1990) Residency in Obstetrics and Gynecology at Northwestern University (1991-1994) Senior Research Fellow in AIDS Research at University of Washington (1994-1998) MPH in Epidemiology from University of Washington School of Public Health (1997) Dr. Cohen's research focuses on reproductive infectious diseases , particularly the etiology and treatment of pelvic inflammatory disease and bacterial vaginosis. His work extends to the prevention of sexually transmitted infections and HIV through microbicides, probiotics, and mechanical barriers. He also investigates the immunopathogenesis of chlamydial infection and aims to improve care for HIV-infected individuals in resource-poor settings, along with developing research infrastructure in developing countries. He is involved in several key initiatives: Family AIDS Care and Education Services (FACES) Infectious Disease Research and Training Program (IDRTP) Reproductive Infectious Disease (RID) Fellowship

Pauline FormaglioView profile

Researcher

• Parasitology
• Malaria Research
• Immunology
• +3 more

Pauline Formaglio is a researcher at the Pasteur Institute in Paris, focusing on Plasmodium species and their interactions with mammalian hosts. Her work primarily investigates the liver stage infection and sporozoite biology of malaria parasites, contributing to the understanding of protective immunological mechanisms and potential vaccine strategies. Publications highlight her expertise in parasite transmission dynamics , host-pathogen interactions , and cell shape maintenance in Plasmodium sporozoites. Recent research includes the cytotoxicity of anti-circumsporozoite antibodies , IL-6-mediated immune modulation , and concanin's role in sporozoite integrity . Her studies often employ in vivo models , 3D substrate assays , and intravital imaging to analyze malaria infection processes. Collaborations span institutions like CNRS and IRD, with work published in top journals such as Immunity , Cell Reports , and Frontiers in Immunology .